Literature DB >> 22839355

Discontinued drugs 2011: pulmonary, allergy, gastrointestinal and arthritis.

Sabina A Antoniu1.   

Abstract

This is the annual perspective paper on the discontinued drugs in the field of pulmonary allergy, gastrointestinal, and arthritis conditions. It is part of series of papers discussing drugs discontinued from clinical development in the previous year and presented according to therapeutic indication. Specifically, this paper presents the 23 compounds developed for various inflammatory conditions and 10 pulmonary drugs which were discontinued in 2011. Information for this perspective was derived from a search of the Pharmaprojects database for drugs discontinued after reaching Phase-I - III clinical trials.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22839355     DOI: 10.1517/13543784.2012.712112

Source DB:  PubMed          Journal:  Expert Opin Investig Drugs        ISSN: 1354-3784            Impact factor:   6.206


  5 in total

1.  Hiding under the skin: Interleukin-17-producing γδ T cells go under the skin?

Authors:  Burkhard Becher; Stanislav Pantelyushin
Journal:  Nat Med       Date:  2012-12       Impact factor: 53.440

Review 2.  Immune responses and therapeutic options in psoriasis.

Authors:  Inna S Afonina; Elien Van Nuffel; Rudi Beyaert
Journal:  Cell Mol Life Sci       Date:  2021-01-02       Impact factor: 9.261

Review 3.  The Role of Helper T Cells in Psoriasis.

Authors:  Peng Hu; Mengyao Wang; Hu Gao; Ai Zheng; Jinhui Li; Dezhi Mu; Jiyu Tong
Journal:  Front Immunol       Date:  2021-12-15       Impact factor: 7.561

Review 4.  Current Concepts of Psoriasis Immunopathogenesis.

Authors:  Marijana Vičić; Marija Kaštelan; Ines Brajac; Vlatka Sotošek; Larisa Prpić Massari
Journal:  Int J Mol Sci       Date:  2021-10-26       Impact factor: 5.923

Review 5.  Update on psoriasis immunopathogenesis and targeted immunotherapy.

Authors:  Satveer K Mahil; Francesca Capon; Jonathan N Barker
Journal:  Semin Immunopathol       Date:  2015-11-16       Impact factor: 9.623

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.